 Channel News Asia | Feuding antibodies blocked HIV vaccine Channel News Asia WASHINGTON: US researchers said Monday that a high-profile HIV vaccine trial that was shown to work in just under a third of patients may have been hindered by feuding antibodies. The vaccine trial, known as RV144, involved more than 16,000 HIV ... |
